| Title |
Author(s) |
Journal |
Issue Date |
Type |
|
Genetic sequencing for surveillance of drug resistance in tuberculosis in highly endemic countries: a multi-country population-based surveillance study
|
Zignol, M.; Cabibbe, A. M.; Dean, A. S.; Glaziou, P.; Alikhanova, N.; Ama, C.; Andres, S.; Barbova, A.; Borbe-Reyes, A.; Chin, D. P.; Cirillo, D. M.; Colvin, C.; Dadu, A.; Dreyer, A.; Driesen, M.; Gilpin, C.; Hasan, R.; Hasan, Z.; Hoffner, S.; Hussain, A.; Ismail, N.; Kamal, S. M. M.; Khanzada, F. M.; Kimerling, M.; Kohl, T. A.; Mansjo, M.; Miotto, P.; Mukadi, Y. D.; Mvusi, L.; Niemann, S.; Omar, S. V.; Rigouts, L.; Schito, M.; Sela, I.; Seyfaddinova, M.; Skenders, G.; Skrahina, A.; Tahseen, S.; Wells, W. A.; Zhurilo, A.; Weyer, K.; Floyd, K.; Raviglione, M. C.
|
Lancet Infectious Diseases |
2018
|
Article
|
|
Some synonymous and non-synonymous gyrA mutations in Mycobacterium tuberculosis lead to systematic false-resistance results to fluoroquinolones with the Hain GenoType MTBDRsl assays
|
Ajileye, A.; Alvarez, N.; Merker, M.; Walker, T. M.; Akter, S.; Brown, K.; Moradigaravand, D.; Schon, T.; Andres, S.; Schleusener, V.; Omar, S. V.; Coll, F.; Huang, H.; Diel, R.; Ismail, N.; Parkhill, J.; de Jong, B. C.; Peto, T. E.; Crook, D. W.; Niemann, S.; Robledo, J.; Smith, E. G.; Peacock, S. J.; Koser, C. U.
|
Antimicrobial Agents and Chemotherapy |
2017
|
Article
|
|
Population-based resistance of Mycobacterium tuberculosis isolates to pyrazinamide and fluoroquinolones: results from a multicountry surveillance project
|
Zignol, M.; Dean, A. S.; Alikhanova, N.; Andres, S.; Cabibbe, A. M.; Cirillo, D. M.; Dadu, A.; Dreyer, A.; Driesen, M.; Gilpin, C.; Hasan, R.; Hasan, Z.; Hoffner, S.; Husain, A.; Hussain, A.; Ismail, N.; Kamal, M.; Mansj”, M.; Mvusi, L.; Niemann, S.; Omar, S. V.; Qadeer, E.; Rigouts, L.; Ruesch-Gerdes, S.; Schito, M.; Seyfaddinova, M.; Skrahina, A.; Tahseen, S.; Wells, W. A.; Mukadi, Y. D.; Kimerling, M.; Floyd, K.; Weyer, K.; Raviglione, M. C.
|
Lancet Infectious Diseases |
2016
|
Article
|